Smouldering myeloma
| Smouldering myeloma | |
|---|---|
| Synonyms | Asymptomatic myeloma |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | None or mild symptoms, may include fatigue, bone pain, or anemia |
| Complications | Progression to multiple myeloma, renal failure, bone fractures |
| Onset | Typically in older adults |
| Duration | Indefinite, can remain stable for years |
| Types | N/A |
| Causes | Unknown, involves abnormal plasma cells |
| Risks | Age, family history, African American ethnicity |
| Diagnosis | Blood test, urine test, bone marrow biopsy |
| Differential diagnosis | Monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma |
| Prevention | N/A |
| Treatment | Observation, regular monitoring, possible early intervention in clinical trials |
| Medication | N/A |
| Prognosis | Variable, risk of progression to multiple myeloma |
| Frequency | Rare, more common than multiple myeloma |
| Deaths | N/A |
Smouldering myeloma (also known as SMM) is a slow-growing type of myeloma that does not cause any symptoms. It is considered a pre-cancerous condition and is often discovered during routine blood tests.
Overview[edit]
Smouldering myeloma is characterized by the presence of abnormal plasma cells in the bone marrow and a high level of monoclonal protein (M protein) in the blood. However, unlike active myeloma, it does not cause any damage to the body and does not require immediate treatment.
Diagnosis[edit]
The diagnosis of smouldering myeloma is based on the following criteria:
- Presence of 10% or more abnormal plasma cells in the bone marrow
- High level of M protein in the blood
- Absence of anemia, high calcium levels, kidney damage, or bone lesions
Treatment[edit]
Currently, there is no standard treatment for smouldering myeloma. Instead, patients are closely monitored for signs of progression to active myeloma. This approach is known as "watchful waiting" or "active surveillance".
Prognosis[edit]
The prognosis for smouldering myeloma varies greatly. Some patients may never develop active myeloma, while others may progress to active myeloma within a few years.
See also[edit]
References[edit]
<references />
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian